[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368879-105":59,"doc-detail-368879-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","flagellins-as-vaccine-adjuvants-and-cancer-immunotherapy-recent-advances-and-future-prospects","Flagellins as Vaccine Adjuvants and Cancer Immunotherapy - Recent Advances and Future Prospects","","Flagellin, a core structural protein of bacterial flagella, is presented as a strong immune modulator capable of enhancing both specific and nonspecific immunity. By triggering pro-inflammatory cytokines such as IL-1β, TNF-α, IL-6, IL-8, and IL-12, flagellin activates innate responses and strengthens antigen-specific adaptive immunity through tumour-targeting type 1 helper T cells and cytotoxic T cells. The review summarizes recent flagellin-based immunotherapy strategies, vaccine adjuvant roles, clinical progress, and potential applications for cancers and infectious diseases, including multidrug-resistant infections.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/flagellins-as-vaccine-adjuvants-and-cancer-immunotherapy-recent-advances-and-future-prospects/368879/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/flagellins-as-vaccine-adjuvants-and-cancer-immunotherapy-recent-advances-and-future-prospects/368879.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What immune functions does flagellin activate in this review?","Question",{"text":112,"@type":113},"Flagellin activates innate immunity by inducing pro-inflammatory cytokines (e.g., IL-1β, TNF-α, IL-6, IL-8, IL-12) and enhances antigen-specific adaptive responses mediated by tumour-specific type 1 helper T cells and cytotoxic T cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is flagellin used as a vaccine adjuvant?",{"text":117,"@type":113},"The review describes flagellin as a potent vaccine adjuvant and carrier, with studies on flagellin from Salmonella species for diseases including HIV, influenza, dengue, West Nile virus, and poultry cholera.",{"name":119,"@type":110,"acceptedAnswer":120},"What roles do flagellin-based approaches play in cancer immunotherapy?",{"text":121,"@type":113},"Flagellin-based treatments, especially when combined with tumour antigens, are reported to enhance anti-tumour immunity and improve patient outcomes, including evidence for effects against various cancers and lung metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368879,1790249086,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Immunology  \nREVIEW  OPEN ACCESS   \nFlagellins as Vaccine Adjuvants and Cancer  \nImmunotherapy: Recent Advances and Future Prospects  \nAsma Talukder | Md. Mijanur Rahman  | Md. Sifat Rahi | Dean L. Pountney | Ming Q. Wei  \nSchool of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Queensland, Australia Correspondence: Md. Mijanur Rahman ([mijanur.rahman@griffithuni.edu.au](mijanur.rahman@griffithuni.edu.au))  \nReceived: 12 February 2025 | Revised: 5 May 2025 | Accepted: 27 May 2025  \nFunding: The authors received no specific funding for this work.  \nKeywords: adjuvants | cancer | flagellin | immunotherapy | infectious diseases | vaccine  \nABSTRACT  \nFlagellin, an essential structural protein of bacterial flagella, has emerged as a potent modulator of both specific and nonspecific immunity, demonstrating significant potential as a vaccine adjuvant and carrier. By inducing the release of pro-inflammatory cytokines like IL-1β, TNF-α, IL-6, IL-8, and IL-12, flagellin activates the innate immune system, enhancing antigen-specific adaptive immune responses mediated by tumour-specific type 1 helper T cells and cytotoxic T cells, thus positioning it as a valuable adjuvant or complementary therapy for various cancers and infectious diseases. This review explores recent strategies, innovations, and clinical applications of flagellin-based immunotherapies, particularly in the context of infectious diseases and cancers. Flagellin from Salmonella typhimurium has been extensively studied as a vaccine adjuvant for diseases like HIV, influenza, dengue, West Nile virus, poultry cholera, and bursal diseases and shows promise in treating lung metastasis, melanoma, colon, and prostate cancers. It has also proven effective against multidrug-resistant bacteria, including Pseudomonas aeruginosa and S. typhimurium. Notably, S. typhimurium flagellin-based vaccines for influenza have progressed to clinical trials. Additionally, flagellins from S. typhi, S. enteritidis, P. aeruginosa, and Escherichia coli are being evaluated as vaccine candidates for plague, malaria, and infections caused by P. aeruginosa and E. coli. In cancer therapy, flagellin-based treatments, especially when combined with tumour antigens, have exhibited the ability to enhance anti-tumour immunity and improve patient outcomes. Other  \n\n| Abbreviations: AI, artificial intelligence; AIV, avian influenza virus; AP-1, activator protein-1; APC, antigen-presenting cell; BALF, bronchoalveolar lavage fluids; CpG-ODNs, cytosine-phosphate-guanine oligodeoxynucleotides; CRP, C-reactive protein; CTCAE, common terminology criteria for adverse events; CTL, cytotoxic T lymphocyte; CTLA-4, cytotoxic T lymphocyte antigen-4; DC, dendritic cell; DENV, dengue virus; ENA-78, epithelial neutrophil activating peptide-78; FaeG, primary subunit of F4 fimbriae; FasL, Fas ligand; FlaB, Vibrio vulnificus flagellin; FMDV, foot and mouth disease virus; fPlpE, Pasteurella multocida lipoprotein E; FRNT50, 50% focus reduction neutralisation tests; G-CSF, granulocyte colony-stimulating factor; gLN, genital lymph node; GMT, geometric mean titres; GRO-α, growth regulated oncogene-α; HA, hemagglutinin; HAI, hemagglutination inhibition; HIV, human immunodeficiency virus; HPV, human papillomavirus; IBD, infectious bursal disease; IBDV, infectious bursal disease virus; IFN, interferon; Ig, immunoglobulin; IkB, inhibitor of kappa B; IL, interleukin; iNOS, inducible nitric oxide synthase; IPAF, ICE protease activating factor; IRAK, interleukin-1 receptor-associated kinase; IRF3, transcription factor interferon regulatory factor 3; IU, international units; IVAG, intravaginal administration; JAK, Janus kinase; LFPS, lipid-A free lipopolysaccharide; LPS, lipopolysaccharide; MAPK, mitogen-activated protein kinase; MDC, macrophage derived chemokine; MDR, multidrug resistant; MHC, major histocompatibility complex; MIP-3α, macrophage inflammatory protein-3α; mL, millilitre; MSP119, 19 kDa C-terminal region of Plasmo","cbCainCiMtX44KcJ","https://ap.wps.com/l/cbCainCiMtX44KcJ","pdf",1668046,27,"English","# Abstract\n## Immunological mechanisms of flagellin\n## Vaccine adjuvant applications in infectious diseases\n## Clinical development and candidate vaccines\n## Flagellin-based strategies in cancer immunotherapy\n## Abbreviations","[{\"question\":\"What immune functions does flagellin activate in this review?\",\"answer\":\"Flagellin activates innate immunity by inducing pro-inflammatory cytokines (e.g., IL-1β, TNF-α, IL-6, IL-8, IL-12) and enhances antigen-specific adaptive responses mediated by tumour-specific type 1 helper T cells and cytotoxic T cells.\"},{\"question\":\"How is flagellin used as a vaccine adjuvant?\",\"answer\":\"The review describes flagellin as a potent vaccine adjuvant and carrier, with studies on flagellin from Salmonella species for diseases including HIV, influenza, dengue, West Nile virus, and poultry cholera.\"},{\"question\":\"What roles do flagellin-based approaches play in cancer immunotherapy?\",\"answer\":\"Flagellin-based treatments, especially when combined with tumour antigens, are reported to enhance anti-tumour immunity and improve patient outcomes, including evidence for effects against various cancers and lung metastasis.\"}]","Flagellins as Vaccine Adjuvants and Cancer Immunotherapy - Recent Advances and Future Prospects | PDF",1790179052,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9157e441f5a604fb2b950e9750d973e5.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7ccd167be07a3f76b986bfff66f436a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db5d7a23c67135a57124ace9c4d1b565.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8f736aa815868a29f225560bf081d31.webp",980,1287]